Zonisamide is a sulfonamide anticonvulsant approved for use as an adjunctive therapy in adults with partial-onset seizures. Zonisamide may be a carbonic anhydrase inhibitor although this is not one of the primary mechanisms of action. Zonisamide may act by blocking repetitive firing of voltage-gated sodium channels leading to a reduction of T-type calcium channel currents, or by binding allosterically to GABA receptors. This latter action may inhibit the uptake of the inhibitory neurotransmitter GABA while enhancing the uptake of the excitatory neurotransmitter glutamate.
Contact Information
9 Squares Building, Monalisha Township
Near Zanzarda Chowkdi, Junagadh 362001 (Gujrat, India)
Structure
Product Description
Details | |
---|---|
Chemical Name |
ZONISAMIDE |
IUPAC Name |
benzo[d]isoxazol-3-ylmethanesulfonamide |
CAS Number |
68291-97-4 |
Molecular Formula |
C8H8N2O3S |
Synonyms |
ZON;ci-912;ad-810;pd110843;excegram;exceglan;Excegran; Zonegran;Excemide;ZONISAMIDE |
Application |
For use as adjunctive treatment of partial seizures in adults with epilepsy. |